Inventors: Dr. Mordehay Vaturi
TriSol Medical – develops a prosthetic percutaneous Tricuspid valve replacement. The Trisol valve is constructed of nitinol frame with specially designed leaflets. Its unique design provides a comprehensive solution to the unique anatomical and functional challenges which arise when treating Tricuspid Regurgitation by a replacement valve.
There are 1.6 million patients suffering from moderate to severe TR in the US. The price of prosthetic valves, which are currently commercial, is around $20K. As such, the total addressable market for Tricuspid replacement valve in the US alone amounts to tens of billions of dollars.